高新興(300098.SZ):業務聚焦於“車聯網及智慧交通”“公共安全”等戰略賽道,主要收入來源於自主研發的產品
格隆匯5月10日丨高新興(300098.SZ)在投資者互動平台表示,公司業務聚焦於“車聯網及智慧交通”“公共安全”等戰略賽道,主要收入來源於自主研發的產品。 交通領域公司自主研發的主要產品有:車聯網前後裝通信終端、電子車牌、車路協同、鐵路軌交產品等,近年在吉利2.0、3.0首發平台和海外項目、鐵路列控GYK-160和周界沿線視頻物聯網產品、電子車牌視射頻一體機V2X協議棧、MEC、雷視融合算法等核心產品投入了較多資源; 公共安全領域公司自主研發的主要產品有:智慧執法辦案平台、執法終端、視頻雲、立體雲防產品等,近年佈局了國產化信創等產品,均獲得了多項產品及業務突破。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.